Validation of Segmental Bioelectrical Impedance Analysis Compared with Dual Energy X-Ray Absorptiometry to Measure Body Composition in Patients with Obesity-related Heart Failure with Preserved Ejection Fraction
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Appendicular lean mass index (ALMI), a term used to describe appendicular lean soft tissue measured by dual-energy X-ray absorptiometry (DXA), is a major determinant of cardiorespiratory fitness in patients with obesity-related heart failure with preserved ejection fraction (HFpEF). Moreover, ALMI can be used to diagnose sarcopenia and sarcopenic obesity in this population. DXA is a reference standard for assessing body composition, however, segmental single-frequency bioelectrical impedance analysis (SF-BIA) could offer a more accessible, portable, cost-effective, and radiation-free alternative. To validate segmental SF-BIA for body composition analysis in patients with HFpEF and obesity, with a focus on ALMI.
Methods
We analyzed 62 consecutive euvolemic patients with persistent obesity-related HFpEF (83.8% female, 60.8± 2.8 years of age). We used both DXA and segmental SF-BIA to measure ALMI and appendicular fat mass index (AFMI), fat mass (FM), fat-free mass (FFM) in kg and as % of body weight, FM index, and FFM index. Correlations were assessed using Pearson’s coefficients and Bland-Altman plots, while linear regression was performed to evaluate proportional bias.
Results
Strong, statistically significant correlations were found between BIA and DXA for ALMI (r=0.897), AFMI (r=0.864), FM (r=0.968), FM% (r=0.867), FFM (r=0.954), and FFM% (r=0.852), FM index (r=0.97), and FFM index (r=0.88) (all p<0.001). The Bland-Altman analysis demonstrated agreement between methods and linear regression indicated no significant proportional bias for all parameters, except for AFMI.
Conclusions
Segmental SF-BIA-measured body composition shows strong correlations, appropriate agreements, and no proportional bias compared to DXA. Considering the central role of body composition and particularly of ALMI in patients with obesity-related HFpEF, when DXA is not readily available or contraindicated, segmental SF-BIA should be considered in this population.
